Last updated: February 12, 2026
What Does the Product Cover?
NDC 00093-0010 refers to a branded or generic drug product. According to standard drug databases and labeling, this specific NDC code corresponds to Chewable Tablets of Bupropion Hydrochloride, 100 mg. It is used primarily for smoking cessation, depression, and bipolar disorder treatment.
Market Size and Demand
- US Prescriptions: The drug's demand is driven by mental health treatments and smoking cessation programs. According to IQVIA data, approximately 2-3 million prescriptions are filled annually for Bupropion in various formulations, with about 30% comprising chewable tablets.
- Therapeutic Competitors: Bupropion faces competition from agents like varenicline (Chantix), nicotine replacement therapies, and other antidepressants.
Market Dynamics
- Current Trends: The increased focus on mental health and smoking cessation, especially post-pandemic, drives continuous demand.
- Regulatory Environment: US FDA approval for Bupropion products is well established. Generic versions have entered the market, exerting downward pressure on prices.
- Reimbursement Factors: Medicare and private insurers largely reimburse this medication, influencing its accessibility and volume.
Price Landscape (As of Q1 2023)
| Product Type |
Approximate Price (per bottle/30 tablets) |
Source |
| Brand (Wellbutrin XL 100 mg) |
$450 - $500 |
GoodRx |
| Generic Bupropion 100 mg |
$60 - $80 |
GoodRx, retail pharmacies |
| Chewable Bupropion 100 mg |
$65 - $85 |
Medicare plan formulary data |
Note: Prices for branded formulations are substantially higher, with generics being 7-8 times cheaper.
Competitive Landscape and Price Trends
- Brand vs. Generic: Generic Bupropion chewables are priced at approximately 15-20% premiums compared to immediate-release tablets but remain significantly lower than brand versions.
- Market Entry Effect: New generics have entered the market over the past five years, reducing the price point for this medication.
- Forecasted Price Trends: Continued generic competition is expected to drive prices downward marginally over the next 2-3 years, with an assumed annual decline of 2-3%.
Price Projection Model (Next 3 Years)
| Year |
Estimated Price Range (per 30 tablets) |
Assumptions and Rationale |
| 2023 |
$65 - $85 |
Current market levels |
| 2024 |
$63 - $82 |
Increased generic penetration |
| 2025 |
$61 - $80 |
Further competition effects |
Market Entry and Potential Revenue
- Branded: Limited growth, mostly retained by existing brand loyalty and insurance coverage.
- Generic: Growth driven by new entrants; projected to account for over 80% of prescriptions within three years.
- Patient Population: Estimated 2 million patients per year in the US, with a shifting preference toward affordable generics.
Regulatory and Policy Impact
- FDA: Slight modifications or new formulations require approval; no major reformulation anticipated.
- Pricing Regulations: Increasing scrutiny on drug pricing could impact wholesale and retail pricing structures.
- Insurance Coverage: Expanded access under Medicare and Medicaid favors stable demand.
Key Takeaways
- The market for NDC 00093-0010 is mature, with significant generic competition.
- Prices have stabilized but are trending downward due to increased generics.
- Demand aligns with mental health and smoking cessation trends, maintaining steady but modest growth.
- Future price reductions are expected, with a classifier for branded products remaining high due to brand loyalty and insurance coverage.
- Competitive dynamics suggest limited potential for significant price increases over the next three years.
FAQs
1. How does the price of this formulation compare globally?
Prices in Europe and Canada are generally lower, especially for generic formulations, due to different regulatory and reimbursement frameworks.
2. What factors influence the price variability within the US?
Insurance formulary placement, pharmacy discounting, and geographic location contribute to price differences, with outpatient pharmacies typically offering the lowest retail prices.
3. Will patent protections impact the pricing of this specific NDC?
As a generic product, patent protections are unlikely to influence prices unless new formulations or orphan drug statuses are pursued.
4. How could new competitors affect market prices?
Additional entrants could increase competition, further lowering prices and market share for existing products.
5. Are compounded versions relevant in this context?
Compounded Bupropion is generally not a substitute for FDA-approved products and is less frequently used due to regulatory and safety concerns, limiting its impact on market pricing.
References
[1] IQVIA National Prescription Data, 2022.
[2] GoodRx Pharmacy Price Data, Q1 2023.
[3] FDA Drug Approvals and Labeling Database.
